Alpa Laboratories Limited

Symbol: ALPA.BO

BSE

90.5

INR

Market price today

  • 10.3959

    P/E Ratio

  • -0.9674

    PEG Ratio

  • 1.90B

    MRK Cap

  • 0.00%

    DIV Yield

Alpa Laboratories Limited (ALPA-BO) Financial Statements

On the chart you can see the default numbers in dynamics for Alpa Laboratories Limited (ALPA.BO). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Alpa Laboratories Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

0808.4702.7424.9
442.7
301.1
178.7
445.1
441.3
721.4
104.6
5.3
1.5
10.4
10.6
12.2

balance-sheet.row.short-term-investments

0720.3687406.9
393
299.6
176.8
421.3
419.4
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0501.4430.8381.4
256.2
315
361.2
409.8
360.4
314
285.1
293.5
321.1
299.6
458.1
502.7

balance-sheet.row.inventory

0126.4154.6165.6
125.5
140.4
137.2
130.4
150
75.2
130
133
155.4
162.7
170.8
226.6

balance-sheet.row.other-current-assets

081.672.7107.8
83.4
37.6
18.1
16.7
16.6
15.7
7.8
5.5
131.3
97.4
6.2
14.3

balance-sheet.row.total-current-assets

01491.21380.11210.9
954.6
940.8
977.2
1046.4
1252.2
1126.3
527.6
437.3
609.3
570
645.7
755.9

balance-sheet.row.property-plant-equipment-net

069.692.287.3
72.3
58.7
61.2
51.8
45.3
48.7
731.1
799.9
682.6
717.2
597.3
535.6

balance-sheet.row.goodwill

0010.6
0
20.2
40.5
60.7
80.9
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

00.810.6
0
0
0
60.7
101.1
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

00.810.6
0
20.2
40.5
60.7
80.9
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

096.561.5104.9
174.9
189.3
129.2
89.8
189.1
107.2
0
0
0
0
0
0

balance-sheet.row.tax-assets

009.30
9.3
1.7
7.6
6.6
6.9
0.9
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

014.58.30
2.4
1.3
-0.4
-0.9
-148.5
107.2
8.4
8.5
8.2
7.6
160.4
295.3

balance-sheet.row.total-non-current-assets

0181.4172.3192.8
258.9
271.2
238
207.9
173.6
156.8
739.5
808.4
690.8
724.8
757.8
830.9

balance-sheet.row.other-assets

0000
0
0.2
0
0.9
0.1
0
0
0
0
0
0
0

balance-sheet.row.total-assets

01672.71552.41403.7
1213.5
1212.2
1215.2
1255.3
1425.9
1283.1
1267.1
1245.7
1300.1
1294.9
1403.5
1586.8

balance-sheet.row.account-payables

0150.6149.2247.3
137
131.9
132.7
139.4
186.6
90.3
106.2
85.2
155.5
184.5
312.4
448.7

balance-sheet.row.short-term-debt

015.337.21.8
2.2
12.6
53.6
102.5
242.3
285.7
160.5
80.4
78.5
94
0
0

balance-sheet.row.tax-payables

022.825.72.9
6.5
0
0
3.1
9.9
0
0
0
0
1.9
1.2
1.1

balance-sheet.row.long-term-debt-total

07.821.20.1
1.9
4.1
6.1
4.7
0
0
42
62
26.7
0
80.8
149.4

Deferred Revenue Non Current

00-25.7-2.2
0
0
0
0
0
0
0
0
0
0
-5.1
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

073.467.438.8
48.6
44.4
30.9
31.5
33.6
36.4
56.3
59.7
51.8
35
41.2
26.1

balance-sheet.row.total-non-current-liabilities

07.821.20.1
1.9
4.2
6.1
145.2
6
5.1
61.1
85.8
36.1
8.3
85.9
156

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0326.9335.1327.3
209.8
227.2
239.8
442.3
503.8
417.5
384
311
321.8
321.9
439.5
630.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0210.4210.4210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4
210.4

balance-sheet.row.retained-earnings

0585.8457.3316.4
243.7
224.9
215.5
53
162.1
105.6
123
174.6
218.3
213
203.9
196

balance-sheet.row.accumulated-other-comprehensive-income-loss

0760760760
760
760
759.9
760
760
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0-210.4-210.4-210.4
-210.4
-210.4
-210.3
-210.4
-210.4
549.6
549.6
549.6
549.6
549.6
549.6
549.6

balance-sheet.row.total-stockholders-equity

01345.81217.31076.4
1003.7
984.9
975.5
813
922.1
865.6
883.1
934.6
978.3
973
964
956

balance-sheet.row.total-liabilities-and-stockholders-equity

01672.71552.41403.7
1213.5
1212.2
1215.2
1255.3
1425.9
1283.1
1267.1
1245.7
1300.1
1294.9
1403.5
1586.8

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

01345.81217.31076.4
1003.7
984.9
975.5
813
922.1
865.6
883.1
934.6
978.3
973
964
956

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

077.774.7101.5
172.9
186.3
128.8
47.9
13.1
101
0
0
0
0
90
236.7

balance-sheet.row.total-debt

02358.51.9
4.1
16.7
59.8
107.2
242.3
285.7
202.5
142.4
105.1
94
80.8
149.4

balance-sheet.row.net-debt

0-65.142.7-16.1
-45.6
15.2
57.9
83.4
220.4
-435.7
97.9
137.2
103.6
83.6
70.2
137.1

Cash Flow Statement

The financial landscape of Alpa Laboratories Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

0156.8195.6107.9
29.1
27.6
46.4
77.5
97.4
-27.1
-49.5
-32.1
8.4
10.8
10.1
0

cash-flows.row.depreciation-and-amortization

013.316.612.3
31.6
31.2
30.7
27.8
8.3
60.7
90.6
47.3
10
11.1
11.7
13

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-814.5-103.4
101.5
-23.9
-163.4
138.5
-284.9
-66.3
14.9
-4.8
-40
31.5
-19.4
5.4

cash-flows.row.account-receivables

0-66.4-0.3-185
97.9
-72.4
12.3
173.7
-121.8
0
0
0
0
0
0
0

cash-flows.row.inventory

028.211-40.1
14.9
-3.2
-6.8
19.6
-74.8
54.9
3
22.4
7.3
8.1
55.8
23.3

cash-flows.row.account-payables

019.8-78.9127.2
-12.1
19
-15.5
-55.2
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

010.382.8-5.5
0.9
32.7
-153.4
0.4
-88.3
-121.2
11.9
-27.2
-47.3
23.3
-75.2
-17.9

cash-flows.row.other-non-cash-items

0-73-127.3-33.8
15.6
-44.9
-40.7
-73.9
-39.4
14.4
24.6
15.2
11.3
-4.4
6.2
2.3

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-11.3-21.9-32.2
-25.5
-8.5
-19.7
-14.1
-106.1
-11.7
-21.9
-38.9
-26.2
-157.8
-85.3
-33.4

cash-flows.row.acquisitions-net

0-542.33.7
13.7
-57.9
-81.3
77.6
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0-0.3-191.87.9
-116.1
-118.7
-98.4
-49.3
-20.6
-101
0
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

012.315.479.1
13.7
38.7
105.1
3.6
0
461.6
0
0
0
96.7
147
53.5

cash-flows.row.other-investing-activites

025.5-0.10.1
2.5
-0.1
-20.4
42.7
46.4
25.4
0
0.4
-3.9
-149.3
-55.6
-5.9

cash-flows.row.net-cash-used-for-investing-activites

021.3-156.158.6
-111.6
-146.6
-114.7
-17.1
-80.3
374.3
-21.9
-38.5
-9.2
-61.2
61.8
42.8

cash-flows.row.debt-repayment

0-35.4-21.2-1.8
-12.7
-43.3
-49.8
-140.7
-43.4
-42
-20
0
0
0
-68.5
-45.5

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-2.575.63.7
-0.8
-4.5
138.1
-11.6
-12.8
110.2
59.2
17.7
0
0
-3.5
-20.7

cash-flows.row.net-cash-used-provided-by-financing-activities

0-37.954.41.9
-13.5
-47.8
88.3
-152.3
-56.2
68.2
39.2
17.7
12.5
10.2
-72
-66.2

cash-flows.row.effect-of-forex-changes-on-cash

000-0.1
0
0
0.1
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

072.4-2.343.4
52.7
-204.4
-153.3
0.4
-355
424.2
97.9
4.8
-7.1
-2
-1.6
-2.7

cash-flows.row.cash-at-end-of-period

088.115.8105.1
61.7
9
213.5
366.8
172.4
527.4
103.2
5.3
0.5
7.6
9.6
11.2

cash-flows.row.cash-at-beginning-of-period

015.81861.7
9
213.4
366.8
366.4
527.4
103.2
5.3
0.5
7.6
9.6
11.2
13.9

cash-flows.row.operating-cash-flow

08999.4-17
177.8
-10.1
-127
169.9
-218.5
-18.4
80.6
25.6
-10.3
49
8.6
20.7

cash-flows.row.capital-expenditure

0-11.3-21.9-32.2
-25.5
-8.5
-19.7
-14.1
-106.1
-11.7
-21.9
-38.9
-26.2
-157.8
-85.3
-33.4

cash-flows.row.free-cash-flow

077.877.5-49.2
152.4
-18.6
-146.7
155.8
-324.6
-30
58.8
-13.3
-36.5
-108.8
-76.6
-12.7

Income Statement Row

Alpa Laboratories Limited's revenue saw a change of NaN% compared with the previous period. The gross profit of ALPA.BO is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

income-statement-row.row.total-revenue

0924.11105.1964.1
848.7
764.2
619
625.4
535.9
573.9
567.1
561.1
551.3
828.7
934.4
1216.8

income-statement-row.row.cost-of-revenue

0615760.9647.6
552.7
530.9
398.1
396.2
307.2
400.1
366.5
403.2
429.8
730.8
843.8
1127.1

income-statement-row.row.gross-profit

0309.1344.3316.6
296.1
233.3
220.9
229.2
228.7
173.8
200.6
157.9
121.5
97.9
90.5
89.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

028.81.50.5
1.1
0.5
0.4
0.1
0.7
1.1
0.1
0.2
0
0.2
0
0

income-statement-row.row.operating-expenses

0235.5248.8219.4
250.8
237.9
199.6
172.6
145.5
192.1
234.5
173.8
105.8
91.5
70.2
78.7

income-statement-row.row.cost-and-expenses

0850.51009.7867
803.5
768.8
597.7
568.8
452.7
592.2
600.9
577
535.6
822.3
914
1205.8

income-statement-row.row.interest-income

010.414.66.5
5.3
29.1
31.8
37.6
40.5
25.6
0.6
0.4
0.3
0.3
0
22.7

income-statement-row.row.interest-expense

00.81.10.3
1
4.8
7.8
16.3
12.8
15
20.9
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

081101.141.7
4.6
28.6
11.4
-19.6
6.6
-34.6
-20.9
-16.3
-7.3
11.2
-8.4
-1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

028.81.50.5
1.1
0.5
0.4
0.1
0.7
1.1
0.1
0.2
0
0.2
0
0

income-statement-row.row.total-operating-expenses

081101.141.7
4.6
28.6
11.4
-19.6
6.6
-34.6
-20.9
-16.3
-7.3
11.2
-8.4
-1

income-statement-row.row.interest-expense

00.81.10.3
1
4.8
7.8
16.3
12.8
15
20.9
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

013.316.612.3
31.6
31.2
30.7
27.8
8.3
60.7
90.6
47.3
10
11.1
11.7
13

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

067.579.669
18.8
-29.7
2.7
38.4
50.2
7.5
-28.6
-15.9
15.7
-0.3
18.5
12.5

income-statement-row.row.income-before-tax

0158.9195.6107.9
29.1
27.6
46.4
56.4
97.4
-27.1
-49.5
-32.1
8.4
10.8
10.1
11.5

income-statement-row.row.income-tax-expense

033.154.735.4
10.5
17.4
18.3
31.2
28.9
-13.1
2
11.6
3.1
1.8
2.2
7.7

income-statement-row.row.net-income

0125.8140.972.5
18.5
10.1
28.1
25.2
68.5
-14
-51.5
-43.7
5.3
9
8
3.8

Frequently Asked Question

What is Alpa Laboratories Limited (ALPA.BO) total assets?

Alpa Laboratories Limited (ALPA.BO) total assets is 1672699000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.350.

What is company free cash flow?

The free cash flow is 7.032.

What is enterprise net profit margin?

The net profit margin is 0.157.

What is firm total revenue?

The total revenue is 0.135.

What is Alpa Laboratories Limited (ALPA.BO) net profit (net income)?

The net profit (net income) is 125828000.000.

What is firm total debt?

The total debt is 23040000.000.

What is operating expences number?

The operating expences are 235520000.000.

What is company cash figure?

Enretprise cash is 0.000.